Matches in Wikidata for { <http://www.wikidata.org/entity/Q66072106> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q66072106 description "clinical trial" @default.
- Q66072106 description "ensayu clínicu" @default.
- Q66072106 description "klinisch onderzoek" @default.
- Q66072106 description "клінічне випробування" @default.
- Q66072106 name "Study of CB-839 in Combination w/ Paclitaxel in Patients of African Ancestry and Non-African Ancestry With Advanced TNBC" @default.
- Q66072106 name "Study of CB-839 in Combination w/ Paclitaxel in Patients of African Ancestry and Non-African Ancestry With Advanced TNBC" @default.
- Q66072106 type Item @default.
- Q66072106 label "Study of CB-839 in Combination w/ Paclitaxel in Patients of African Ancestry and Non-African Ancestry With Advanced TNBC" @default.
- Q66072106 label "Study of CB-839 in Combination w/ Paclitaxel in Patients of African Ancestry and Non-African Ancestry With Advanced TNBC" @default.
- Q66072106 prefLabel "Study of CB-839 in Combination w/ Paclitaxel in Patients of African Ancestry and Non-African Ancestry With Advanced TNBC" @default.
- Q66072106 prefLabel "Study of CB-839 in Combination w/ Paclitaxel in Patients of African Ancestry and Non-African Ancestry With Advanced TNBC" @default.
- Q66072106 P1132 Q66072106-5D3F7721-1E64-40CB-9E9D-6FD066059AFE @default.
- Q66072106 P1476 Q66072106-14F185AA-FE12-4DAE-AD01-5894A362363A @default.
- Q66072106 P17 Q66072106-1AD10A1D-72ED-4F8A-82E4-411AC6925007 @default.
- Q66072106 P2899 Q66072106-1C9628E0-87F6-46E7-9954-009742E2D54B @default.
- Q66072106 P3098 Q66072106-57479C3F-B0D2-45C5-8D76-2D87DD51E196 @default.
- Q66072106 P31 Q66072106-1C5B1345-168A-485E-B13E-1D17B9AE99E4 @default.
- Q66072106 P4844 Q66072106-393E0C9F-9535-498E-8C53-54AEC2060C96 @default.
- Q66072106 P580 Q66072106-04686852-F5DD-4594-896C-6E1CD2E5AA02 @default.
- Q66072106 P582 Q66072106-F7F8CBD9-0BD2-44D9-A277-16981DE07CDC @default.
- Q66072106 P6099 Q66072106-07A3BB0E-E923-407B-829C-06AB244D435B @default.
- Q66072106 P6153 Q66072106-725E2A82-E17B-4DE6-B53F-43BE95481D0A @default.
- Q66072106 P6153 Q66072106-731E63F4-475B-4F28-9CAD-504AC2CD6E8A @default.
- Q66072106 P6153 Q66072106-89E4D87C-97C3-43EC-B93E-DA716EABBA56 @default.
- Q66072106 P6153 Q66072106-8D10B2C9-F0EF-4FE9-B69E-8475B0673635 @default.
- Q66072106 P6153 Q66072106-DBBFAA34-4A23-4A64-860A-66DB8A2DE59D @default.
- Q66072106 P8363 Q66072106-30AE54AD-404D-4177-9660-70E776301676 @default.
- Q66072106 P1132 "+112" @default.
- Q66072106 P1476 "A Multicenter Phase 2 Study of the Glutaminase Inhibitor CB-839 in Combination With Paclitaxel in Patients With Advanced Triple Negative Breast Cancer (TNBC) Including Patients of African Ancestry and Non-African Ancestry" @default.
- Q66072106 P17 Q30 @default.
- Q66072106 P2899 "+18" @default.
- Q66072106 P3098 "NCT03057600" @default.
- Q66072106 P31 Q30612 @default.
- Q66072106 P4844 Q423762 @default.
- Q66072106 P580 "2017-05-09T00:00:00Z" @default.
- Q66072106 P582 "2019-06-30T00:00:00Z" @default.
- Q66072106 P6099 Q42824440 @default.
- Q66072106 P6153 Q2892284 @default.
- Q66072106 P6153 Q49088 @default.
- Q66072106 P6153 Q734774 @default.
- Q66072106 P6153 Q738258 @default.
- Q66072106 P6153 Q7896459 @default.
- Q66072106 P8363 Q78089383 @default.